A bacterial stimulation assay for bronchoalveolar lavage immune cells from young children with cystic fibrosis.

Autor: Liu H; Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, Vic., Australia.; Department of Pediatric Respiratory Medicine, Xin Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China., Sarkar S; Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, Vic., Australia., Azzopardi K; Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, Vic., Australia., Day S; Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, Vic., Australia., Yeow S; Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, Vic., Australia., Ranganathan S; Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, Vic., Australia.; Department of Paediatrics, University of Melbourne, Parkville, Vic., Australia.; Department of Respiratory and Sleep Medicine, Royal Children's Hospital, Melbourne, Vic., Australia., Sutton P; Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, Vic., Australia.; Department of Paediatrics, University of Melbourne, Parkville, Vic., Australia.
Jazyk: angličtina
Zdroj: Scandinavian journal of immunology [Scand J Immunol] 2021 Jul; Vol. 94 (1), pp. e13040. Date of Electronic Publication: 2021 Apr 03.
DOI: 10.1111/sji.13040
Abstrakt: Cystic Fibrosis (CF) is primarily a progressive lung disease, characterized by chronic pulmonary infections with opportunistic pathogens. Such infections typically commence early in life, producing an inflammatory response marked by IL-8 chemokine production and neutrophilic infiltration, major contributory factors in CF progression. Studying this inflammation, especially early in life, is critical for developing new strategies for preventing or slowing disruption to the structural integrity of the CF airways. However, evaluating the immune responses of bronchoalveolar lavage (BAL) cells from children with CF faces technical challenges, including contamination carried from the lung due to pre-existing infections and low cell number availability. Here, we describe a technique for preparing BAL cells from young children with CF and using those cells in a bacterial stimulation assay. Initial antibiotic treatment proved essential for preventing resident bacteria from overgrowing BAL cell cultures, or non-specifically activating the cells. ACTB, identified as an optimal reference gene, was validated for accurate analysis of gene expression in these cells. Pseudomonas aeruginosa and Staphylococcus aureus were used as bacterial stimulants to evaluate the immune response of BAL cells from young children with CF. Addition of gentamicin prevented bacterial overgrowth, although if added after 3 hours of culture an extremely variable response resulted, with the bacteria causing a suppressive effect in some cultures. Addition of gentamicin after 1 hour of culture completely prevented this suppressive effect. This technique was then able to reproducibly measure the IL-8 response to stimulation with S. aureus and P. aeruginosa, including co-stimulation with both bacteria.
(© 2021 The Scandinavian Foundation for Immunology.)
Databáze: MEDLINE
Externí odkaz: